CTBO (Cantabio Pharmaceuticals) Beginning Cash Position: $0.02 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Beginning Cash Position?

Cantabio Pharmaceuticals CTBO Beginning Cash Position is $0.02 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2018 was $0.02 Mil.

Cantabio Pharmaceuticals's quarterly Beginning Cash Position increased from Jun. 2018 ($0.11 Mil) to Sep. 2018 ($0.19 Mil) but then declined from Sep. 2018 ($0.19 Mil) to Dec. 2018 ($0.02 Mil).

Cantabio Pharmaceuticals's annual Beginning Cash Position increased from Mar. 2016 ($-0.00 Mil) to Mar. 2017 ($0.05 Mil) but then declined from Mar. 2017 ($0.05 Mil) to Mar. 2018 ($0.03 Mil).

Cantabio Pharmaceuticals Beginning Cash Position Related Terms

Cantabio Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Beginning Cash Position Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Beginning Cash Position
Get a 7-Day Free Trial 0.02 0.00 -0.00 0.05 0.03

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.03 0.11 0.19 0.02

Cantabio Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.02 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Beginning Cash Position of $0.02 Mil as of Dec. 2018. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Beginning Cash Position too high?
Cantabio Pharmaceuticals' current Beginning Cash Position is $0.02 Mil.
How does Cantabio Pharmaceuticals' Beginning Cash Position compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Beginning Cash Position of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Beginning Cash Position is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Beginning Cash Position of $0.02 Mil. The current Beginning Cash Position is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Beginning Cash Position is $0.02 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.